Cargando…

Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study

Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkuraishy, Hayder M., Al-Gareeb, Ali I., Albuhadilly, Ali K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274818/
https://www.ncbi.nlm.nih.gov/pubmed/25548768
http://dx.doi.org/10.1155/2014/324307
_version_ 1782350041029017600
author Alkuraishy, Hayder M.
Al-Gareeb, Ali I.
Albuhadilly, Ali K.
author_facet Alkuraishy, Hayder M.
Al-Gareeb, Ali I.
Albuhadilly, Ali K.
author_sort Alkuraishy, Hayder M.
collection PubMed
description Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age range 50–65 years, normotensive with history of cerebrovascular disorders, were selected according to the American Heart Stroke Association. Blood viscosity and other rheological parameters were measured after two-day abstinence from any medications. Dual effects of vinpocetine and pyritinol exhibit significant effects on all hemorheological parameters (P < 0.05), especially on low shear whole blood viscosity (P < 0.01), but they produced insignificant effects on total serum protein and high shear whole blood viscosity (P > 0.05). Therefore, joint effects of vinpocetine and pyritinol improve blood and plasma viscosity in patients with cerebrovascular disorders.
format Online
Article
Text
id pubmed-4274818
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42748182014-12-29 Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study Alkuraishy, Hayder M. Al-Gareeb, Ali I. Albuhadilly, Ali K. Biomed Res Int Clinical Study Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age range 50–65 years, normotensive with history of cerebrovascular disorders, were selected according to the American Heart Stroke Association. Blood viscosity and other rheological parameters were measured after two-day abstinence from any medications. Dual effects of vinpocetine and pyritinol exhibit significant effects on all hemorheological parameters (P < 0.05), especially on low shear whole blood viscosity (P < 0.01), but they produced insignificant effects on total serum protein and high shear whole blood viscosity (P > 0.05). Therefore, joint effects of vinpocetine and pyritinol improve blood and plasma viscosity in patients with cerebrovascular disorders. Hindawi Publishing Corporation 2014 2014-12-07 /pmc/articles/PMC4274818/ /pubmed/25548768 http://dx.doi.org/10.1155/2014/324307 Text en Copyright © 2014 Hayder M. Alkuraishy et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Alkuraishy, Hayder M.
Al-Gareeb, Ali I.
Albuhadilly, Ali K.
Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title_full Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title_fullStr Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title_full_unstemmed Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title_short Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
title_sort vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274818/
https://www.ncbi.nlm.nih.gov/pubmed/25548768
http://dx.doi.org/10.1155/2014/324307
work_keys_str_mv AT alkuraishyhayderm vinpocetineandpyritinolanewmodelforbloodrheologicalmodulationincerebrovasculardisordersarandomizedcontrolledclinicalstudy
AT algareebalii vinpocetineandpyritinolanewmodelforbloodrheologicalmodulationincerebrovasculardisordersarandomizedcontrolledclinicalstudy
AT albuhadillyalik vinpocetineandpyritinolanewmodelforbloodrheologicalmodulationincerebrovasculardisordersarandomizedcontrolledclinicalstudy